Washington – A new study reported by USA Today, says that the mRNA vaccine technology, originally focusing on cancer treatments, can now be used for infectious diseases. The study was presented recently at a research conference that highlighted “after nearly two years, patients who received mRNA vaccine jabs created by Moderna and Merck 44% avoided new tumours and were more likely to be alive than those who received normal cancer care.”
